Entities / Company
OrbiMed.
Investment service in New York City, New York
- Reports this week
- 0
- Active events
- 0
- Connections
- 19
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
-
OrbiMed secured a $400 million senior secured term loan facility, retained TD Cowen as financial advisor, and must file details with the SEC.Some support3 reports
-
J. Mark Joyce completed residency training at Emory University, while Iain D. Dukes serves as an advisor for Dogwood Therapeutics through OrbiMed.Some support1 report
Gone quiet
No new reports in 90+ days-
Renasant Bio announced its launch from Berkeley after securing investments from Atlas Venture and OrbiMed.Some support1 report
-
OrbiMed promoted Mona Ashiya to general partner, noting the company's team is based in New York City.Some support1 report
-
OrbiMed announced it secured a $200 million credit facility and filed a Current Report on Form 8-K with the SEC on July 31, 2025.Some support1 report
No events began in the chosen period. Widen it, or reset.
Connections
The 1 strongest of 19, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Intellia Therapeutics Transactional
A secured a $400 million senior secured term loan facility.
History
Events by the month they beganSeptember 2026
1 eventAugust 2026
1 eventJune 2026
3 events- Renasant Bio announced its launch from Berkeley after securing investments from Atlas Venture and OrbiMed.
- OrbiMed promoted Mona Ashiya to general partner, noting the company's team is based in New York City.
- OrbiMed announced it secured a $200 million credit facility and filed a Current Report on Form 8-K with the SEC on July 31, 2025.